This peptide can guide drugs and imaging agents to acute brain injuries and result in enhanced benefit. The peptide was identified by Aman Mann and Pablo Scodeller in the lab of Dr. Erkki Ruoslahti in collaboration with the cancer biology lab.

Link to the paper: Nature Communications

Links to news:Nature Reviews Chemical and Engineering News Novaator Science Daily The San Diego Union Tribute

Image: The tiny peptide CAQK improves the delivery of imaging agents to acute brain injuries.  (Luminiscence from porous silicon nanoparticles targeted with CAQK and control peptide CGGK in brain injuries)